Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients

Background: The ESE-ENSAT guidelines on the management of adrenocortical carcinoma (ACC) suggest adjuvant mitotane for patients at high risk of recurrence following radical surgery. This indication has a limited evidence base, lacking results from randomized controlled trials. No suggestion for or a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Endocr Soc
Main Authors: Terzolo, Massimo, Fassnacht, Martin, Perotti, Paola, Libe, Rossella, Lacroix, André, Kastelan, Darko, Haak, Harm Reinout, Arlt, Wiebke, Loli, Paola, Decoudier, Bénédicte, Lasolle, Helene, Bancos, Irina, Quinkler, Marcus, Villares Fragoso, Maria Candida Barisson, Canu, Letizia, Puglisi, Soraya, Kroiss, Matthias, Dusek, Tina, Bourdeau, Isabelle, Baudin, Eric, Berchialla, Paola, Beuschlein, Felix, Bertherat, Jerome Yves, Berruti, Alfredo
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Adrenal
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8265733/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.336
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares